Oncology
🇺🇸 FDA Page 13FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 145–156 of 246 articles
Tempest Therapeutics Achieves Manufacturing Milestone for TPST-2003 CAR-T Cancer Treatment
NETRIS Pharma's NP137 Shows Promising Results in Pancreatic Cancer Phase 1b Trial Published in Nature
Mabwell 9MW2821 Combination Therapy Data to Be Presented at ASCO 2026 for Urothelial Carcinoma Treatment
FDA Issues Complete Response Letter for Atara Biotherapeutics' EBVALLO Cancer Treatment, Triggering Securities Lawsuit
ImmunityBio (IBRX) Faces Securities Lawsuit After FDA Warning Letter Over Cancer Treatment Claims
Labcorp Launches FDA-Approved PD-L1 Companion Diagnostic for KEYTRUDA Ovarian Cancer Treatment
FDA Update: Patritumab Deruxtecan in Novel Brain Metastasis Therapies
AACR 2026: ctDNA, Immunotherapy, and KRAS Target Breakthroughs
Pfizer Presents LORBRENA and BRAFTOVI Cancer Trial Updates at ASCO 2026
Avacta's AVA6103 Cancer Drug Shows Superior Profile vs Enhertu in AACR 2026 Data
Innovent Biologics IBI363 Clinical Data to Be Presented at ASCO 2026 Annual Meeting
FDA Extends Sanofi Sarclisa Subcutaneous Review by Three Months for Multiple Myeloma Treatment